* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Tuesday, September 30, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Good Deed Entertainment Acquires Worldwide Rights To Liza Mandelup’s Documentary ‘Caterpillar’ – Deadline

    Good Deed Entertainment Lands Global Rights to Liza Mandelup’s Captivating Documentary ‘Caterpillar

    Danielle Fishel Explains Why Being on “DWTS” Makes Her Feel ‘Like It’s 1994 Again’ Filming “Boy Meets World” (Exclusive) – Yahoo

    Danielle Fishel Explains Why Being on “DWTS” Makes Her Feel ‘Like It’s 1994 Again’ Filming “Boy Meets World” (Exclusive) – Yahoo

    Jussie Smollett Claims He Was ‘Disrespected’ on the ‘Special Forces’ Season Premiere – Yahoo

    Jussie Smollett Opens Up About Feeling ‘Disrespected’ During the ‘Special Forces’ Season Premiere

    TicketSmarter Fall Entertainment Guide – Eastern Illinois University Athletics

    TicketSmarter Fall Entertainment Guide – Eastern Illinois University Athletics

    Cardi B Adds More Dates to Little Miss Drama Tour: ‘Y’all Making Me Work’ – Yahoo

    Cardi B Extends Little Miss Drama Tour: “Y’all Making Me Work

    ‘Today’: Sheinelle Jones Thanks Katie Couric for Support After Husband’s Death – CBS 19 News

    Sheinelle Jones Expresses Heartfelt Thanks to Katie Couric for Support After Husband’s Passing

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Four Strategic Signals Technology Leaders Are Tuning In To – SPONSOR CONTENT FROM ARM – Harvard Business Review

    Four Essential Strategic Signals Every Technology Leader Should Watch

    Virginia Tech hosts annual New Music + Technology Festival this week – Cardinal News

    Virginia Tech Kicks Off Exciting Annual New Music and Technology Festival This Week

    Why I gave the world wide web away for free | Tim Berners-Lee – The Guardian

    Why I Decided to Make the World Wide Web Free for Everyone | Tim Berners-Lee

    From shale to steam: Fossil fuel technology boosts clean geothermal energy – Washington Examiner

    From Shale to Steam: How Fossil Fuel Technology is Powering a Clean Geothermal Energy Revolution

    How Sustainable Technology is Shaping a Greener Future – Technology Magazine

    How Sustainable Technology is Driving the Revolution Toward a Greener Future

    Aurora police hope to add facial recognition technology to crime-fighting tools – CBS News

    Aurora Police Aim to Boost Crime-Fighting with New Facial Recognition Technology

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Good Deed Entertainment Acquires Worldwide Rights To Liza Mandelup’s Documentary ‘Caterpillar’ – Deadline

    Good Deed Entertainment Lands Global Rights to Liza Mandelup’s Captivating Documentary ‘Caterpillar

    Danielle Fishel Explains Why Being on “DWTS” Makes Her Feel ‘Like It’s 1994 Again’ Filming “Boy Meets World” (Exclusive) – Yahoo

    Danielle Fishel Explains Why Being on “DWTS” Makes Her Feel ‘Like It’s 1994 Again’ Filming “Boy Meets World” (Exclusive) – Yahoo

    Jussie Smollett Claims He Was ‘Disrespected’ on the ‘Special Forces’ Season Premiere – Yahoo

    Jussie Smollett Opens Up About Feeling ‘Disrespected’ During the ‘Special Forces’ Season Premiere

    TicketSmarter Fall Entertainment Guide – Eastern Illinois University Athletics

    TicketSmarter Fall Entertainment Guide – Eastern Illinois University Athletics

    Cardi B Adds More Dates to Little Miss Drama Tour: ‘Y’all Making Me Work’ – Yahoo

    Cardi B Extends Little Miss Drama Tour: “Y’all Making Me Work

    ‘Today’: Sheinelle Jones Thanks Katie Couric for Support After Husband’s Death – CBS 19 News

    Sheinelle Jones Expresses Heartfelt Thanks to Katie Couric for Support After Husband’s Passing

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    Four Strategic Signals Technology Leaders Are Tuning In To – SPONSOR CONTENT FROM ARM – Harvard Business Review

    Four Essential Strategic Signals Every Technology Leader Should Watch

    Virginia Tech hosts annual New Music + Technology Festival this week – Cardinal News

    Virginia Tech Kicks Off Exciting Annual New Music and Technology Festival This Week

    Why I gave the world wide web away for free | Tim Berners-Lee – The Guardian

    Why I Decided to Make the World Wide Web Free for Everyone | Tim Berners-Lee

    From shale to steam: Fossil fuel technology boosts clean geothermal energy – Washington Examiner

    From Shale to Steam: How Fossil Fuel Technology is Powering a Clean Geothermal Energy Revolution

    How Sustainable Technology is Shaping a Greener Future – Technology Magazine

    How Sustainable Technology is Driving the Revolution Toward a Greener Future

    Aurora police hope to add facial recognition technology to crime-fighting tools – CBS News

    Aurora Police Aim to Boost Crime-Fighting with New Facial Recognition Technology

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Ozanimod Controls MS Disease Activity Regardless of Age

March 4, 2024
in Health
Ozanimod Controls MS Disease Activity Regardless of Age
Share on FacebookShare on Twitter

WEST PALM BEACH, Fla. — Clinical and radiologic measures of disease activity remained stable or improved for relapsing multiple sclerosis (RMS) patients in all age groups over 7 to 8 years of continuous treatment with ozanimod (Zeposia).

“Regardless of age category, the adjusted annualized relapse rate was below 0.2 in the phase III parent trials and remained low in the DAYBREAK open-label extension in patients treated with continuous ozanimod,” said Jeffrey Cohen, MD, of the Cleveland Clinic in Ohio, in a poster presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum.

A total of 2,257 RMS patients in the parent SUNBEAM and RADIANCE trials participated in the open-label DAYBREAK extension study. By age category, the number of patients treated continuously with 0.92 mg ozanimod from the start of the phase III trials included 118 people ages 25 or younger, 268 people ages 26 to 35, 313 people ages 36 to 50, and 62 people ages 50 and older.

Patients continually taking ozanimod, an oral sphingosine 1-phosphate (S1P) receptor 1 and 5 modulator, had consistently lower rates of relapse and almost always had numerically lower rates of relapse than those who originally received interferon beta-1a before being switched to ozanimod, Cohen said.

“We also noted that even the patients who started the trial on interferon, when they switched to ozanimod in the open-label extension, they basically caught up to the people who were on ozanimod the entire length of the phase III trials and the extension,” he told MedPage Today.

There were similar relationships on age for the number of gadolinium-enhancing lesions, which averaged 0.6 per scan throughout the open-label extension, Cohen added. The number of new or enlarging T2 lesions per scan was reduced as patients got older, he said.

“This is something that has been observed in relapsing multiple sclerosis over time,” Cohen noted. A decline in these lesions may be part of declining immune activity as people age, he suggested. Long-term treatment also may interrupt the cascade of molecular inflammatory events that can cause nerve injury, he noted.

Ozanimod was approved to treat RMS in 2020 based on data from the pivotal SUNBEAM and RADIANCE studies, which showed lower relapse rates with ozanimod compared with interferon beta-1a. Patients who completed SUNBEAM and RADIANCE were eligible to enroll in the open-label extension of ozanimod 0.92 mg.

Cohen explained that while the relapses and appearance of new lesions remained low overall in the extension study, the team wanted to determine whether those rates diminished with age.

The findings should be reassuring to clinicians who are treating older patients with ozanimod for long durations, noted Patrick Vermersch, MD, PhD, of University Hospital Lille in France, who wasn’t involved with the study.

“When you treat long-term with these immune-modulating agents, there is always a concern that the risk of infections can occur, and the risk would be greater in an older patient,” Vermersch told MedPage Today. “We did not see this occur in patients in the DAYBREAK study.”

In a companion study presented at the meeting, Cohen and colleagues reported that the final analysis of the DAYBREAK extension study showed that treatment with 0.92 mg ozanimod controlled disease activity for longer than previously reported — a mean of 60.9 months, with some patients having been on treatment for 117.2 months (i.e., nearly 10 years).

“Ozanimod was generally well tolerated, with 78.2% of participants completing the study,” Cohen said. “Ozanimod demonstrated sustained efficacy with a low annualized relapse rate of 0.098, low numbers of new or enlarging T2 lesions of an average of less than 1 new or enlarging lesion per scan at 60 months, and mean number of gadolinium-enhancing lesions on brain MRI of an average of about 0.24 lesions per scan at 60 months.”

The safety findings were consistent with phase III trials and the established safety profile of ozanimod, Cohen noted.

“While we rarely would start a patient on interferons or glatiramer acetate these days but rather on disease-modifying agents, it is still good that we have this data to show there is an advantage to the use of these newer agents such as ozanimod,” he said.

author['full_name']

Ed Susman is a freelance medical writer based in Fort Pierce, Florida, USA.

Disclosures

The ozanimod studies were sponsored by Bristol Myers Squibb.

Cohen disclosed financial relationships with Astoria, Bristol Myers Squibb, Convelo, EMD Serono, Find Therapeutics, INmune, and Sandoz.

Vermersch disclosed relationships with Bristol-Myers Squibb, Novartis, Merck, EMD Serono, Biogen, and Sanofi.

Primary Source

Americas Committee for Treatment and Research in Multiple Sclerosis Forum

Source Reference: Cree BAC, et al “Long-term efficacy of the sphingosine 1-phosphate receptor modulator ozanimod by age category in patients with relapsing multiple sclerosis: final results from two phase 3 trials and an open-label extension trial” ACTRIMS Forum 2024; poster P091.

Secondary Source

Americas Committee for Treatment and Research in Multiple Sclerosis Forum

Source Reference: Selmaj KW, et al “Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: final analysis of the DAYBREAK open-label extension study” ACTRIMS Forum 2024; poster P090.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/actrims/108994

Tags: ControlshealthOzanimod
Previous Post

“I Have the Unfortunate Genetics That I Am Bald”: What We Heard This Week

Next Post

School Shootings in U.S. Reach Highest Recorded Levels

Common juniper, the oldest nonclonal woody species across the tundra biome and the European continent – ESA Journals

Discovering the Common Juniper: The Oldest Nonclonal Woody Species Across the Tundra and Europe

September 30, 2025
What Forensic Science Is and How to Become a Forensic Scientist | Education | U.S. News – U.S. News & World Report

Unlocking the Secrets of Forensic Science: Your Guide to Becoming a Forensic Scientist

September 30, 2025
BLM celebrates International Archaeology Day at the Campbell Creek Science Center – Bureau of Land Management (.gov)

BLM Celebrates International Archaeology Day with Exciting Events at Campbell Creek Science Center

September 30, 2025
Sagittarius Daily Horoscope Today (Nov 22- Dec 21), September 30, 2025: Lifestyle will get refined! – India Today

Sagittarius Daily Horoscope Today (Nov 22- Dec 21), September 30, 2025: Lifestyle will get refined! – India Today

September 30, 2025
Four Strategic Signals Technology Leaders Are Tuning In To – SPONSOR CONTENT FROM ARM – Harvard Business Review

Four Essential Strategic Signals Every Technology Leader Should Watch

September 30, 2025

Latest sportsbook receives Missouri license through partnership with Royals – KCTV

September 30, 2025
World-Building With Daisies – 032C

Bringing Color to Life: The Art of Building Vibrant Worlds with Daisies

September 29, 2025
Milei Vowed to Fix Argentina’s Economy. Then Came a New Crisis. – The New York Times

Milei Vowed to Fix Argentina’s Economy. Then Came a New Crisis. – The New York Times

September 29, 2025
Good Deed Entertainment Acquires Worldwide Rights To Liza Mandelup’s Documentary ‘Caterpillar’ – Deadline

Good Deed Entertainment Lands Global Rights to Liza Mandelup’s Captivating Documentary ‘Caterpillar

September 29, 2025
Report finds increased nitrates as fertilizer application poses costs to public health and farmers – Wisconsin Examiner

Rising Nitrate Levels from Fertilizer Use Threaten Public Health and Farmers’ Livelihoods

September 29, 2025

Categories

Archives

September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (843)
  • Economy (864)
  • Entertainment (21,738)
  • General (17,320)
  • Health (9,907)
  • Lifestyle (877)
  • News (22,149)
  • People (866)
  • Politics (874)
  • Science (16,074)
  • Sports (21,364)
  • Technology (15,847)
  • World (846)

Recent News

Common juniper, the oldest nonclonal woody species across the tundra biome and the European continent – ESA Journals

Discovering the Common Juniper: The Oldest Nonclonal Woody Species Across the Tundra and Europe

September 30, 2025
What Forensic Science Is and How to Become a Forensic Scientist | Education | U.S. News – U.S. News & World Report

Unlocking the Secrets of Forensic Science: Your Guide to Becoming a Forensic Scientist

September 30, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version